Montelukast Sodium Tablet, Chewable
Brand names: Singulair
Category: Pulmonary/Allergy
FDA status: To Be Discontinued · Last FDA update: Nov 17, 2025 · First posted: Nov 17, 2025 · 1 manufacturers, 1 listed presentations
As of Nov 17, 2025, the FDA lists Montelukast Sodium Tablet, Chewable as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Singulair, Tablet, Chewable, 4 mg (NDC 78206-170-01) NDC 78206-170-01 |
Organon | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Pulmonary/Allergy medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Montelukast Sodium Tablet, Chewable (FDA data as of Nov 17, 2025). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Montelukast Sodium Tablet, Chewable. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/montelukast-sodium-tablet-chewable.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).